In accordance with Article 3 of Regulation (EC) No 470/2009, pharmacologically active substances intended for use in the Union in veterinary medicinal products administered to food-producing animals are subject to an opinion of the European Medicines Agency (‘the Agency’) regarding their maximum residue limits (‘MRLs’).
Recital 1, Regulation (EU) 2025/1101
In forcesince 3 Jun 2025